Premium
GAO criticizes CMS for burying Medicare SUD information
Author(s) -
Knopf Alison
Publication year - 2020
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32736
Subject(s) - medicaid , methadone , medicine , opioid overdose , opioid , accountability , government (linguistics) , opioid use disorder , medicare/medicaid , family medicine , business , psychiatry , political science , law , health care , (+) naloxone , linguistics , philosophy , receptor
When the January 2020 edition of Medicare & You , the guide the Centers for Medicare & Medicaid Services (CMS) issues to beneficiaries every year, was released, there was a brief description of the new coverage benefit for Medicare beneficiaries with opioid use disorders (OUDs): treatment for opioid use disorders, including methadone maintenance in an opioid treatment program. However, the booklet does not include anything explicit, and this can lead to Medicare beneficiaries not seeking needed treatment, according to a study by the Government Accountability Office (GAO), which also reviewed the fall 2019 edition of Medicare & You and found a similar lack of information.